Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 6051–6100 of 75455
each of Alan Masarek, Shai Terem, Edward T. Anderson, Michael Medici, Paul Milbury, Carol Meyers, Antonio Rodriguez, Aaron VanDevender and George Riedel resigned from the Board and from any and all committees thereof on which they served and ceased to be directors of the Company
each of Alan Masarek, Shai Terem, Edward T. Anderson, Michael Medici, Paul Milbury, Carol Meyers, Antonio Rodriguez, Aaron VanDevender and George Riedel resigned from the Board and from any and all committees thereof on which they served and ceased to be directors of the Company
each of Alan Masarek, Shai Terem, Edward T. Anderson, Michael Medici, Paul Milbury, Carol Meyers, Antonio Rodriguez, Aaron VanDevender and George Riedel resigned from the Board and from any and all committees thereof on which they served and ceased to be directors of the Company
On April 24, 2025, Assaf Zipori informed the Board of Directors of the Company (the “Board”) that he would resign from his position as Chief Financial Officer, Treasurer and Secretary of the Company, effective immediately
On April 25, 2025, Mark Iwicki provided notice of his resignation from the board of directors (the “Board”) of Q32 Bio Inc. (the “Company”), effective as of December 31, 2025
On April 24, 2025, the board of directors (the "Board") of Chewy, Inc. (the "Company") increased the size of the Board from thirteen to fourteen directors and filled the newly created vacancy by appointing Dr. Nat Goldhaber (the "New Director") as a Class I director, with a term expiring at the Company's annual meeting of stockholders in 2026.
On April 22, 2025, Christopher G. Hayes notified Verrica Pharmaceuticals Inc. (the “ Company ”) that he will resign from his positions as the Company’s Chief Legal Officer, Chief Compliance Officer and Corporate Secretary effective as of April 30, 2025
Effective April 23, 2025 Mr. Coleman and Mr. Smith were appointed as Co-Chairs of the Board
On April 23, 2025, in connection with the IPO, Leo Valentine, Rick Mazer, Daniel Ginsberg, Timothy Gannon and Greg Stevens (collectively with Alexander Coleman and Gary Smith, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).
On April 23, 2025, in connection with the IPO, Leo Valentine, Rick Mazer, Daniel Ginsberg, Timothy Gannon and Greg Stevens (collectively with Alexander Coleman and Gary Smith, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).
Effective April 23, 2025 Mr. Coleman and Mr. Smith were appointed as Co-Chairs of the Board
On April 23, 2025, in connection with the IPO, Leo Valentine, Rick Mazer, Daniel Ginsberg, Timothy Gannon and Greg Stevens (collectively with Alexander Coleman and Gary Smith, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).
On April 23, 2025, in connection with the IPO, Leo Valentine, Rick Mazer, Daniel Ginsberg, Timothy Gannon and Greg Stevens (collectively with Alexander Coleman and Gary Smith, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).
On April 23, 2025, in connection with the IPO, Leo Valentine, Rick Mazer, Daniel Ginsberg, Timothy Gannon and Greg Stevens (collectively with Alexander Coleman and Gary Smith, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).
On April 24, 2025, each of Craig Barbarosh, David Coulter and Richard Kerley resigned from the Board, effective April 24, 2025.
On April 24, 2025, the board of directors (the “Board”) of ModivCare Inc. (the “Company”) appointed Daniel Silvers as a member of the Board, effective April 24, 2025.
On April 24, 2025, each of Craig Barbarosh, David Coulter and Richard Kerley resigned from the Board, effective April 24, 2025.
On April 24, 2025, each of Craig Barbarosh, David Coulter and Richard Kerley resigned from the Board, effective April 24, 2025.
On April 24, 2025, Daniel Springer notified Docusign, Inc. (the “Company”) of his resignation from the Company’s Board of Directors, effective immediately.
On April 21, 2025, George T. Hicks, Executive Vice President – Finance and Treasurer of Brookdale Senior Living Inc. (the “Company”), notified the Company that, after 40 years with the Company and its predecessors, he would be retiring on May 21, 2025.
On April 22, 2025, Ms. Cathy Hendrickson notified the Board of Directors (the “Board”) of Kennedy-Wilson Holdings, Inc. (the “Company”) that she is retiring from the Board, effective June 5, 2025, the date of the Company's 2025 annual meeting of stockholders.
appointed Michael Van de Ven and Lawson Whiting as independent members of the Board, effective April 24, 2025.
On April 21, 2025, the Board of Directors ("Board") of Keurig Dr Pepper Inc. (the "Company") approved Robert Gamgort's transition from the role of Executive Chairman to non-employee Chairman of the Board, effective April 24, 2025.
appointed Michael Van de Ven and Lawson Whiting as independent members of the Board, effective April 24, 2025.
On April 24, 2025, the Board appointed Shelton (Shelly) Palmer as a director of the Company for the term expiring at the Company’s 2025 Annual Shareholders' Meeting and appointed Mr. Palmer to the Technology & Cybersecurity Committee of the Board.
On April 24, 2025, the Board of Directors (the "Board") of 1-800-FLOWERS.COM, INC. (the "Company") appointed Priscilla Kasenchak as Chief Accounting Officer of the Company.
Armando Alexandri was appointed by the Board of Directors of the Company as Chief Operating Officer of the Company, effective as of April 22, 2025.
Effective April 21, 2025, Alberto Reyes is no longer employed as the Chief Operating Officer of Gold Resource Corporation (the “Company”). The termination of his employment with the Company is without cause.
On April 22, 2025, Mark D. Stolper, a member of the Board of Directors (the “Board”) of Coherus BioSciences, Inc. (the “Company”), notified the Board of his intention not to stand for re-election to the Board for an additional three-year term at the Company's 2025 Annual Meeting of Stockholders (the “2025 Annual Meeting”).
Mr. Parsley will cease to serve as Chief Operating Officer of the Corporation effective July 1, 2025 (the "Transition Date").
On April 21, 2025, Robert S. Strong, a director of the Company and the Bank, notified the Company he will retire from the Company’s Board on June 17, 2025, the date of the Company’s next annual meeting of stockholders.
On April 23, 2025, the Board of Directors (the “Board”) of SLM Corporation (the “Company”) appointed Dr. Daniel Greenstein and Mr. Gary Millerchip as directors of the Company, effective April 23, 2025.
On April 23, 2025, the Board of Directors (the “Board”) of SLM Corporation (the “Company”) appointed Dr. Daniel Greenstein and Mr. Gary Millerchip as directors of the Company, effective April 23, 2025.
On April 21, 2025, Kevin Fogarty advised the Board of Directors (the “Board”) of OPAL Fuels Inc. (the “Company”) that he will not be standing for re-election to the Board at the Company’s 2025 Annual Meeting of Stockholders (the “Annual Meeting”).
On April 25, 2025, Thomas Finke advised the Board of Directors of Alliance Entertainment Holding Corporation (the “Company”) that he is resigning as a director of the Company effective May 1, 2025.
Effective as of April 21, 2025, Mads Andersen, age 59, was appointed to the Board of Directors of Koil Energy Solutions, Inc. (the “Company”) as an independent, non-executive director.
On April 21, 2025, the Company announced the appointment of Kurt Keller as the chief financial officer (CFO) of the Company.
On April 24, 2025, John McKenna, Executive Vice President of Tompkins Financial Corporation (the “Company”) and President of Tompkins Community Bank (the “Bank”) announced his decision to retire as an officer of the Company and the Bank in the summer of 2026, after more than 17 years of service.
On April 24, 2025, the Company announced that it had appointed Shane Campbell to serve as Senior Vice President, Chief Proprietary Segment Officer, effective May 5, 2025
On April 22, 2025, Mr. Bernard Birkett notified West Pharmaceutical Services, Inc. (the “Company”) of his intention to retire as Senior Vice President & Chief Financial Officer later this year.
On April 23, 2025, the Board appointed Jeff Epstein and Anna Christine Simons to the Board, effective immediately following the conclusion of the 2025 Annual Meeting.
On April 23, 2025, the Board appointed Jeff Epstein and Anna Christine Simons to the Board, effective immediately following the conclusion of the 2025 Annual Meeting.
On April 24, 2025, Encompass Health issued a press release announcing the appointment of Patrick W. Tuer as Executive Vice President and Chief Operating Officer
He was serving as the Board’s Chairman and a member of each of the Compensation Committee and Nominating and Governance Committee, and in connection with his appointment, Mr. Pace has resigned from these roles.
announced the appointment of David A. Pace to the position of President and Chief Executive Officer (“President and CEO”) of the Company, effective April 24, 2025
Mr. Pace replaces G.J. Hart as the Company’s President and CEO, who will also depart from the Board of Directors (the “Board”) of the Company as of the Effective Date.
On April 22, 2025, Mary Elizabeth Hunsberger, 50, was appointed by the board of directors (the “Board”) of Culp, Inc. (the “Company”) to serve as Chief Operating Officer of the Company
Ms. Weisner notified the Company that she has chosen not to stand for re-election when her term expires at the 2025 Annual Meeting
the Company entered into a consulting agreement with Mr. Jiang to serve as a special strategic advisor to the Company’s Asia Pacific business through the end of fiscal 2025, in the temporary role of Chief of APAC Strategy
the Board appointed Louis E. Silverman, who served on the Company’s Board from 2014-2022, as a director, effective April 24, 2025
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.